Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Iron is an integral cofactor in many metabolic processes involved in transcriptional signaling, synapse formation and
neuroplasticity, in all of which a function for amyloid-β precursor protein (APP) has also been heavily implicated but
remained unclear. Imbalances in intraneuronal iron are a predominant catalyst for the production of reactive oxygen species,
particularly within iron accumulating neurodegenerative diseases such as Alzheimer�s disease. While APP has historically been
associated with AD due to the prevalence of the APP derived amyloid-β (Aβ) peptide within insoluble extracellular �plaques�
deposited within the AD brain, we recently discovered that APP has a role in neuronal iron homeostasis by, in part, promoting
iron efflux through cell surface stabilization of the iron pore ferroportin. Detailed cell surface characterization confirms that
the location of ferroportin on the neuron surface is increased upon iron incubation and is dependent upon APP. By altering
the trafficking of APP to the cell surface via tau or the proteolytic processing of APP, consequential changes in neuronal
iron homeostasis arise. Deletion of tau decreased cell surface APP expression, resulting in an age-dependent neuronal iron
accumulation that parallels studies with APP depletion. Comparably, enhancing the amyloidogenic pathway of APP processing,
leads to intracellular iron accumulation. With increased amyloidogenic processing of APP and post-translational modification
of tau being major contributors to sporadic AD, these studies increase our understanding as to why iron accumulation and
increased susceptibility to reactive oxygen species neurotoxicity are prevalent with this disease.
Biography
James A Duce completed his PhD in 2002 from University of Wales College of Medicine, Cardiff before leaving the UK to study in the US and Australia. At present he
concurrently runs research teams at the University of Leeds, UK and The Florey Institute of Neuroscience and Mental Health in Melbourne Australia. In recognition
of his strong involvement in identifying the iron regulatory role of β-Amyloid precursor protein (APP) through tau�s assistance in its transport to the neuron surface
he was recently awarded the JBC/Herb Tabor Young International Investigator award. Continued support is provided through an Alzheimer�s Research UK Senior
Research Fellowship and projects funded by the European Research Council and Australian National Health and Medical Research Council.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals